Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Li, Cheng ^a   Miao, Xiao ^b   Li, Fengsheng ^c   Wang, Shudong ^a   Liu, Quan ^a   Wang, Yonggang ^a   Sun, Jian ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; DISEASE CONTROL; GLUCOSE; OCCUPATIONAL DISEASES; OXIDATIVE STRESS;

ANIMAL EXPERIMENTS; ANTIOXIDANT DEFENSE SYSTEM; ANTIOXIDANT THERAPIES; BLOOD GLUCOSE CONCENTRATION; CLINICAL TRIAL; DIABETIC RETINOPATHY; REACTIVE OXYGEN SPECIES; THERAPEUTIC STRATEGY;

EYE PROTECTION;

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BENFOTIAMINE; BETA CAROTENE; CAFFEIC ACID PHENETHYL ESTER; CANNABIDIOL; CURCUMIN; FUMARIC ACID DIMETHYL ESTER; GUANINE NUCLEOTIDE BINDING PROTEIN; HEMIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; METFORMIN; MICRORNA; MYCOPHENOLATE MOFETIL; NICANARTINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLTIPRAZ; REACTIVE OXYGEN METABOLITE; SILENT INFORMATION REGULATOR PROTEIN 2; SINECATECHINS; SULFORAPHANE; TAURINE; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; TROLOX C; XANTHOPHYLL; ZINC;

DIABETIC RETINOPATHY; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATION; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; REVIEW; TEA; ANIMAL; DRUG EFFECTS;

ANTIOXIDANTS; DIAGNOSIS; DISEASES;

ANIMALS; ANTIOXIDANTS; DIABETIC RETINOPATHY; HUMANS; OXIDATIVE STRESS;

EID: 85013455579     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/9702820     Document Type: Review

References (157)

1. N. H. Cho, "Q&A: five questions on the 2015 IDF diabetes atlas, " Diabetes Research and Clinical Practice, vol. 115, pp. 157-159, 2016.
2. S. Resnikoff, D. Pascolini, D. Etya'ale et al., "Global data on visual impairment in the year 2002, " Bulletin of theWorldHealth Organization, vol. 82, no. 11, pp. 844-851, 2004.
3. Y. Zheng, M. He, and N. Congdon, "The worldwide epidemic of diabetic retinopathy, " Indian Journal of Ophthalmology, vol. 60, no. 5, pp. 428-431, 2012.
4. R. N. Frank, "Diabetic retinopathy, "The New England Journal of Medicine, vol. 350, no. 1, pp. 48-58, 2004.
5. F. Giacco and M. Brownlee, "Oxidative stress and diabetic complications, " Circulation Research, vol. 107, no. 9, pp. 1058-1070, 2010.
6. R. A. Kowluru and P.-S. Chan, "Oxidative stress and diabetic retinopathy, " Experimental Diabesity Research, vol. 2007, Article ID 43603, 12 pages, 2007.
7. Q. Zhong, M. Mishra, and R. A. Kowluru, "Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 54, no. 6, pp. 3941-3948, 2013.
8. G. Mohammad and R. A. Kowluru, "The role of Raf-1 kinase in diabetic retinopathy, " ExpertOpinion onTherapeutic Targets, vol. 15, no. 4, pp. 357-364, 2011.
9. R. A. Kowluru, J. M. Santos, and M. Mishra, "Epigenetic modifications and diabetic retinopathy, " BioMed Research International, vol. 2013, Article ID 635284, 9 pages, 2013.
10. R. V. Intine and M. P. Sarras Jr., "Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms, " Current Diabetes Reports, vol. 12, no. 5, pp. 551-559, 2012.
11. S. Sharma, S. Saxena, K. Srivastav et al., "Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations, " Clinical & Experimental Ophthalmology, vol. 43, no. 5, pp. 429-436, 2015.
12. T.-R. Golden and S. Melov, "Mitochondrial DNA mutations, oxidative stress, and aging, " Mechanisms of Ageing and Development, vol. 122, no. 14, pp. 1577-1589, 2001.
13. J.-M. Li and A. M. Shah, "ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy, " Journal of the American Society of Nephrology, vol. 14, no. 8, supplement 3, pp. S221-S226, 2003.
14. Y. Du, C. M. Miller, and T. S. Kern, "Hyperglycemia increases mitochondrial superoxide in retina and retinal cells, " Free Radical Biology andMedicine, vol. 35, no. 11, pp. 1491-1499, 2003.
15. S. A. Madsen-Bouterse, G. Mohammad, M. Kanwar, and R. A. Kowluru, "Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression, " Antioxidants & Redox Signaling, vol. 13, no. 6, pp. 797-805, 2010.
16. M. Mishra and R. A. Kowluru, "Epigenetic modification of mitochondrial DNA in the development of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 56, no. 9, pp. 5133-5142, 2015.
17. C. Szabó, H. Ischiropoulos, and R. Radi, "Peroxynitrite: biochemistry, pathophysiology and development of therapeutics, " Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662-680, 2007.
18. I. M. Goldstein, P. Ostwald, and S. Roth, "Nitric oxide: A review of its role in retinal function and disease, " Vision Research, vol. 36, no. 18, pp. 2979-2994, 1996.
19. J. M. Santos, S. Tewari, and R. A. Kowluru, "A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy, " Free Radical Biology & Medicine, vol. 53, no. 9, pp. 1729-1737, 2012.
20. T. Ago, J. Kuroda, M. Kamouchi, J. Sadoshima, and T. Kitazono, "Pathophysiological roles of NADPH oxidase/Nox family proteins in the vascular system-review and perspective, " Circulation Journal, vol. 75, no. 8, pp. 1791-1800, 2011.
21. M. Rojas, W. Zhang, Z. Xu et al., "Requirement of NOX2 expression in both retina and bone marrow for diabetesinduced retinal vascular injury, " PLoSONE, vol. 8, no. 12, Article ID e84357, 2013.
22. F. Chen, L.-H. Qian, B. Deng, Z.-M. Liu, Y. Zhao, and Y.-Y. Le, "Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress, " CNS Neuroscience& Therapeutics, vol. 19, no. 9, pp. 675-681, 2013.
23. H. Ding, M. Aljofan, and C. R. Triggle, "Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells, " Journal of Cellular Physiology, vol. 212, no. 3, pp. 682-689, 2007.
24. P. Weidig, D. McMaster, and U. Bayraktutan, "High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells, "Diabetes, Obesity&Metabolism, vol. 6, no. 6, pp. 432-441, 2004.
25. J. Cunha-Vaz and R. Bernardes, "Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes, " Progress in Retinal and Eye Research, vol. 24, no. 3, pp. 355-377, 2005.
26. S. Roy, T. Sato, G. Paryani, and R. Kao, "Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats, " Diabetes, vol. 52, no. 5, pp. 1229-1234, 2003.
27. J. Kim, C.-S. Kim, Y. M. Lee, K. Jo, S. D. Shin, and J. S. Kim, "Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases, " Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 5, pp. 691-697, 2012.
28. V. E. Kagan, A. A. Shvedova, K. N. Novikov, and Y. P. Kozlov, "Light-induced free radical oxidation of membrane lipids in photoreceptors of frog retina, " Biochimica et Biophysica Acta-Biomembranes, vol. 330, no. 1, pp. 76-79, 1973.
29. M. E. Hartnett, R. D. Stratton, R. W. Browne, B. A. Rosner, R. J. Lanham, and D. Armstrong, "Serum markers of oxidative stress and severity of diabetic retinopathy, " Diabetes Care, vol. 23, no. 2, pp. 234-240, 2000.
30. R. A. Kowluru and P. Koppolu, "Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy, " Free Radical Research, vol. 36, no. 9, pp. 993-999, 2002.
31. R. A. Kowluru, P. Koppolu, S. Chakrabarti, and S. Chen, "Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants, " Free Radical Research, vol. 37, no. 11, pp. 1169-1180, 2003.
32. Y. Du, A. Veenstra, K. Palczewski, and T. S. Kern, "Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 41, pp. 16586-16591, 2013.
33. B. A. Berkowitz, E. M. Grady, N. Khetarpal, A. Patel, and R. Roberts, "Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 56, no. 1, pp. 606-615, 2015.
34. G. B. Arden, "The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment, " The British Journal of Ophthalmology, vol. 85, no. 3, pp. 366-370, 2001.
35. G. B. Arden, J. E. Wolf, and Y. Tsang, "Does dark adaptation exacerbate diabetic retinopathy Evidence and a linking hypothesis, " Vision Research, vol. 38, no. 11, pp. 1723-1729, 1998.
36. T. E. deGooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. A. Gardiner, and A. W. Stitt, "Retinopathy is reduced during experimental diabetes in amouse model of outer retinal degeneration, " Investigative Ophthalmology & Visual Science, vol. 47, no. 12, pp. 5561-5568, 2006.
37. P. Pacher, I. G. Obrosova, J. G. Mabley, and C. Szabó, "Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies, " Current Medicinal Chemistry, vol. 12, no. 3, pp. 267-275, 2005.
38. E. C. Leal, A. Manivannan, K.-I. Hosoya et al., "Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 48, no. 11, pp. 5257-5265, 2007.
39. Z. Yuan, W. Feng, J. Hong, Q. Zheng, J. Shuai, and Y. Ge, "p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose, " Nitric Oxide: Biology and Chemistry, vol. 20, no. 1, pp. 9-15, 2009.
40. K. H. Gabbay, "The sorbitol pathway and the complications of diabetes, "The New England Journal ofMedicine, vol. 288, no. 16, pp. 831-836, 1973.
41. D. G. Cogan, J. H. Kinoshita, P. F. Kador et al., "NIH conference. Aldose reductase and complications of diabetes, " Annals of Internal Medicine, vol. 101, no. 1, pp. 82-91, 1984.
42. A. B. El-Remessy, G. Abou-Mohamed, R. W. Caldwell, and R. B. Caldwell, "High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation, " Investigative Ophthalmology & Visual Science, vol. 44, no. 7, pp. 3135-3143, 2003.
43. M. Clarke and P. M. Dodson, "PKC inhibition and diabetic microvascular complications, " Best Practice & Research Clinical Endocrinology & Metabolism, vol. 21, no. 4, pp. 573-586, 2007.
44. K. Suzuma, N. Takahara, I. Suzuma et al., "Characterization of protein kinase C isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 721-726, 2002.
45. J. Park, H. Kim, S. Y. Park et al., "Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C in a mouse model of diabetic retinopathy, " Experimental Eye Research, vol. 122, pp. 13-19, 2014.
46. P. Geraldes, J. Hiraoka-Yamamoto, M. Matsumoto et al., "Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy, " Nature Medicine, vol. 15, no. 11, pp. 1298-1306, 2009.
47. C. A. Aveleira, C. M. Lin, S. F. Abcouwer, A. F. Ambrosio, and D. A. Antonetti, "TNF-alpha signals through PKCzeta/NFkappaB to alter the tight junction complex and increase retinal endothelial cell permeability, " Diabetes, vol. 59, no. 11, pp. 2872-2882, 2010.
48. R. D. Minshall, E. E. Vandenbroucke, M. Holinstat et al., "Roleof protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers, " Microvascular Research, vol. 80, no. 2, pp. 240-249, 2010.
49. E. D. Schleicher, A. Bierhaus, H.-U. Häring, P. P. Nawroth, and R. Lehmann, "Chemistry and pathobiology of advanced glycation end products, " Contributions to Nephrology, no. 131, pp. 1-9, 2001.
50. A. W. Stitt, "AGEs and diabetic retinopathy, " Investigative Ophthalmology& Visual Science, vol. 51, no. 10, pp. 4867-4874, 2010.
51. D. A. Kass, E. P. Shapiro, M. Kawaguchi et al., "Improved arterial compliance by a novel advanced glycation end-product crosslink breaker, " Circulation, vol. 104, no. 13, pp. 1464-1470, 2001.
52. A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager, "Advanced glycation end products: sparking the development of diabetic vascular injury, " Circulation, vol. 114, no. 6, pp. 597-605, 2006.
53. S. Yoshida, Y. Kubo, Y. Kobayashi et al., "Increased vitreous concentrations ofMCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema, " The British Journal of Ophthalmology, vol. 99, no. 7, pp. 960-966, 2015.
54. S.-I. Yamagishi, K. Nakamura, T. Matsui et al., "Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression, " The Journal of Biological Chemistry, vol. 281, no. 29, pp. 20213-20220, 2006.
55. X. Du, T. Matsumura, D. Edelstein et al., "Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells, " The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049-1057, 2003.
56. S. J. Kim, W. S. Yoo, M. Choi, I. Chung, J. M. Yoo, and W. S. Choi, "Increased O-GlcNAcylation of NF-kappaB enhances retinal ganglion cell death in Streptozotocin-induced diabetic retinopathy, " Current Eye Research, vol. 41, no. 2, pp. 249-257, 2016.
57. D. Yao, T. Taguchi, T. Matsumura et al., "High glucose increases angiopoietin-2 transcription in microvascular endothelial cells throughmethylglyoxal modification ofmSin3A, " The Journal of Biological Chemistry, vol. 282, no. 42, pp. 31038-31045, 2007.
58. Q. Ma, L. Battelli, and A. F. Hubbs, "Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2, " The American Journal of Pathology, vol. 168, no. 6, pp. 1960-1974, 2006.
59. Y. Wei, J. Gong, T. Yoshida et al., "Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemiareperfusion injury, " Free Radical Biology &Medicine, vol. 51, no. 1, pp. 216-224, 2011.
60. T. W. Kensler, N. Wakabayashi, and S. Biswal, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway, " Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89-116, 2007.
61. Z. Xu, Y. Wei, J. Gong et al., "NRF2 plays a protective role in diabetic retinopathy in mice, " Diabetologia, vol. 57, no. 1, pp. 204-213, 2014.
62. M. Mishra, Q. Zhong, and R. A. Kowluru, "Epigeneticmodifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression, " Free Radical Biology&Medicine, vol. 75, pp. 129-139, 2014.
63. D. Guo, B. Wu, J. Yan, X. Li, H. Sun, and D. Zhou, "A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells, " Biochemical and Biophysical Research Communications, vol. 428, no. 1, pp. 80-85, 2012.
64. M. Mishra, Q. Zhong, and R. A. Kowluru, "Epigeneticmodifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 55, no. 11, pp. 7256-7265, 2014.
65. L. Zhou, D.-Y. Xu, W.-G. Sha et al., "High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway, " Journal of TranslationalMedicine, vol. 13, no. 1, article 352, 2015.
66. G. Eades, M. Yang, Y. Yao, Y. Zhang, and Q. Zhou, "miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells, " The Journal of Biological Chemistry, vol. 286, no. 47, pp. 40725-40733, 2011.
67. X. Zhou, J. Su, L. Zhu, and G. Zhang, "Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by downregulating miR-141 expression, " Helicobacter, vol. 19, no. 3, pp. 174-181, 2014.
68. Y. Takai, T. Sasaki, and T. Matozaki, "Small GTP-binding proteins, " Physiological Reviews, vol. 81, no. 1, pp. 153-208, 2001.
69. S. Schubbert, G. Bollag, and K. Shannon, "Deregulated Ras signaling in developmental disorders: newtricks for an old dog, " Current Opinion in Genetics & Development, vol. 17, no. 1, pp. 15-22, 2007.
70. T.-H. Cheng, N.-L. Shih, S.-Y. Chen et al., "Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells, " Journal of Molecular and Cellular Cardiology, vol. 33, no. 10, pp. 1805-1814, 2001.
71. G. Cuda, R. Paternò, R. Ceravolo et al., "Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling, " Circulation, vol. 105, no. 8, pp. 968-974, 2002.
72. R. A. Kowluru and M. Kanwar, "Translocation of H-Ras and its implications in the development of diabetic retinopathy, " Biochemical and Biophysical Research Communications, vol. 387, no. 3, pp. 461-466, 2009.
73. K. Irani, Y. Xia, J. L. Zweier et al., "Mitogenic signalingmediated by oxidants in Ras-transformed fibroblasts, " Science, vol. 275, no. 5306, pp. 1649-1652, 1997.
74. K. N. Meadows, P. Bryant, P. A. Vincent, and K. M. Pumiglia, "Activated Ras induces a proangiogenic phenotype in primary endothelial cells, " Oncogene, vol. 23, no. 1, pp. 192-200, 2004.
75. R. A. Kowluru, A. Kowluru, S. Chakrabarti, and Z. Khan, "Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats, " Diabetes, vol. 53, no. 3, pp. 775-783, 2004.
76. M. Kanwar and R. A. Kowluru, "Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy, " Microvascular Research, vol. 76, no. 3, pp. 189-193, 2008.
77. V. Kowluru and R. A. Kowluru, "Increased oxidative stress in diabetes regulates activation of a small molecular weight Gprotein, H-Ras, in the retina, "Molecular Vision, vol. 13, pp. 602-610, 2007.
78. R. A. Kowluru, "Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by HRas, " Investigative Ophthalmology andVisual Science, vol. 51, no. 8, pp. 4320-4326, 2010.
79. A. Das, A. McLamore, W. Song, and P. G. McGuire, "Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor, " Archives of Ophthalmology, vol. 117, no. 4, pp. 498-503, 1999.
80. K. W. Lee, M.-S. Kim, N. J. Kang et al., "H-Ras selectively upregulates MMP-9 and COX-2 through activation of ERK1/2 and NF-B: An implication for invasive phenotype in rat liver epithelial cells, " International Journal of Cancer, vol. 119, no. 8, pp. 1767-1775, 2006.
81. T. A. Giambernardi, G. M. Grant, G. P. Taylor et al., "Overview of matrix metalloproteinase expression in cultured human cells, " Matrix Biology, vol. 16, no. 8, pp. 483-496, 1998.
82. R. Arita, Y. Hata, S. Nakao et al., "Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage, " Diabetes, vol. 58, no. 1, pp. 215-226, 2009.
83. M. V. Hoang, M. C. Whelan, and D. R. Senger, "Rho activity critically and selectively regulates endothelial cell organization during angiogenesis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 1874-1879, 2004.
84. K. Hirayama, Y. Hata, Y. Noda et al., "The involvement of the Rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes, " Investigative Ophthalmology & Visual Science, vol. 45, no. 11, pp. 3896-3903, 2004.
85. K. E. Kammand J. T. Stull, "The function ofmyosin andmyosin light chain kinase phosphorylation in smooth muscle, " Annual Review of Pharmacology and Toxicology, vol. 25, pp. 593-620, 1985.
86. Y. Fukata, M. Amano, and K. Kaibuchi, "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells, " Trends in Pharmacological Sciences, vol. 22, no. 1, pp. 32-39, 2001.
87. R. A. Kowluru, A. Kowluru, M. Mishra, and B. Kumar, "Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy, " Progress in Retinal and Eye Research, vol. 48, pp. 40-61, 2015.
88. A. M. Deaton and A. Bird, "CpG islands and the regulation of transcription, " Genes & Development, vol. 25, no. 10, pp. 1010-1022, 2011.
89. R. A. Kowluru, Y. Shan, and M. Mishra, "Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy, " Laboratory Investigation, vol. 96, no. 10, pp. 1040-1049, 2016.
90. S. Majumdar, E. Buckles, J. Estrada, and S. Koochekpour, "Aberrant DNA methylation and prostate cancer, " Current Genomics, vol. 12, no. 7, pp. 486-505, 2011.
91. P. Zhang, B. Huang, X. Xu, andW. C. Sessa, "Ten-eleven translocation (Tet) and thymineDNA glycosylase (TDG), components of the demethylation pathway, are direct targets ofmiRNA-29a, " Biochemical and Biophysical Research Communications, vol. 437, no. 3, pp. 368-373, 2013.
92. S. Tewari, Q. Zhong, J. M. Santos, and R. A. Kowluru, "Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 53, no. 8, pp. 4881-4888, 2012.
93. N. Dhliwayo, M. P. Sarras Jr., E. Luczkowski, S. M. Mason, and R. V. Intine, "Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation, " Diabetes, vol. 63, no. 9, pp. 3069-3076, 2014.
94. T. Kouzarides, "Chromatin modifications and their function, " Cell, vol. 128, no. 4, pp. 693-705, 2007.
95. C. Martin and Y. Zhang, "Thediverse functions of histone lysine methylation, " Nature Reviews Molecular Cell Biology, vol. 6, no. 11, pp. 838-849, 2005.
96. M. Wegner, D. Neddermann, M. Piorunska-Stolzmann, and P. P. Jagodzinski, "Role of epigenetic mechanisms in the development of chronic complications of diabetes, " Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 164-175, 2014.
97. Q. Zhong and R. A. Kowluru, "Role of histone acetylation in the development of diabetic retinopathy and the metabolicmemory phenomenon, " Journal of Cellular Biochemistry, vol. 110, no. 6, pp. 1306-1313, 2010.
98. L. Perrone, T. S. Devi, K.-I. Hosoya, T. Terasaki, and L. P. Singh, "Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions, " Journal of Cellular Physiology, vol. 221, no. 1, pp. 262-272, 2009.
99. D. Brasacchio, J. Okabe, C. Tikellis et al., "Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail, " Diabetes, vol. 58, no. 5, pp. 1229-1236, 2009.
100. Q. Zhong andR. A. Kowluru, "Regulationofmatrixmetalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy, " Diabetes, vol. 62, no. 7, pp. 2559-2568, 2013.
101. Q. Zhong and R. A. Kowluru, "Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation, " Investigative Ophthalmology & Visual Science, vol. 54, no. 1, pp. 244-250, 2013.
102. F. Miao, X. Wu, L. Zhang, Y.-C. Yuan, A. D. Riggs, andR. Natarajan, "Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in humanmonocytes, " The Journal of Biological Chemistry, vol. 282, no. 18, pp. 13854-13863, 2007.
103. J.-M. Yun, I. Jialal, and S. Devaraj, "Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin, " The Journal of Nutritional Biochemistry, vol. 22, no. 5, pp. 450-458, 2011.
104. D.-I. Kim, M.-J. Park, S.-K. Lim et al., "High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy, "Archives of Biochemistry and Biophysics, vol. 560, pp. 36-43, 2014.
105. D.-I. Kim, M.-J. Park, J.-H. Choi et al., "PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independentmanners, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 617919, 9 pages, 2015.
106. D. M. Dykxhoorn, C. D. Novina, and P. A. Sharp, "Killing the messenger: short RNAs that silence gene expression, " Nature Reviews Molecular Cell Biology, vol. 4, no. 6, pp. 457-467, 2003.
107. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function, " Cell, vol. 116, no. 2, pp. 281-297, 2004.
108. A. Zampetaki, S. Kiechl, I. Drozdov et al., "PlasmamicroRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes, " Circulation Research, vol. 107, no. 6, pp. 810-817, 2010.
109. A. R. Murray, Q. Chen, Y. Takahashi, K. K. Zhou, K. Park, and J.-X. Ma, "MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model, " Investigative Ophthalmology & Visual Science, vol. 54, no. 3, pp. 1689-1697, 2013.
110. N. Dey, A. Bera, F. Das, N. Ghosh-Choudhury, B. S. Kasinath, and G. G. Choudhury, "High glucose enhances microRNA-26ato activate mTORC1 for mesangial cell hypertrophy and matrix protein expression, " Cellular Signalling, vol. 27, no. 7, pp. 1276-1285, 2015.
111. J. H. Suh, E. Choi, M.-J. Cha et al., "Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3 protein expression, " Biochemical and Biophysical Research Communications, vol. 423, no. 2, pp. 404-410, 2012.
112. Z. Chen, T.-P. Shentu, L. Wen, D. A. Johnson, and J. Y.-J. Shyy, "Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium, " Antioxidants & Redox Signaling, vol. 19, no. 13, pp. 1522-1538, 2013.
113. N. D'Onofrio, M. Vitiello, R. Casale, L. Servillo, A. Giovane, and M. L. Balestrieri, "Sirtuins in vascular diseases: emerging roles and therapeutic potential, " Biochimica et BiophysicaActa-Molecular Basis of Disease, vol. 1852, no. 7, pp. 1311-1322, 2015.
114. Y. Colak, O. Ozturk, E. Senates et al., "SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease, " Medical Science Monitor, vol. 17, no. 5, pp. HY5-HY9, 2011.
115. A. Biason-Lauber, M. Böni-Schnetzler, B. P. Hubbard et al., "Identification of a SIRT1 mutation in a family with type 1 diabetes, " Cell Metabolism, vol. 17, no. 3, pp. 448-455, 2013.
116. E. Jing, B. Emanuelli, M. D. Hirschey et al., "Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14608-14613, 2011.
117. S. Bhattacharya, E. Chaum, D. A. Johnson, and L. R. Johnson, "Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association, " Investigative Ophthalmology & Visual Science, vol. 53, no. 13, pp. 8350-8366, 2012.
118. S. Kubota, Y. Ozawa, T. Kurihara et al., "Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation, " Investigative Ophthalmology and Visual Science, vol. 52, no. 12, pp. 9142-9148, 2011.
119. J.-H. Lee, M.-Y. Song, E.-K. Song et al., "Overexpression of SIRT1 protects pancreatic-cells against cytokine toxicity by suppressing the nuclear factor-B signaling pathway, " Diabetes, vol. 58, no. 2, pp. 344-351, 2009.
120. E. M. Dioum, R. Chen, M. S. Alexander et al., "Regulation of hypoxia-inducible factor 2 signaling by the stress-responsive deacetylase sirtuin 1, " Science, vol. 324, no. 5932, pp. 1289-1293, 2009.
121. Y. Zeng, K. Yang, F. Wang et al., "The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression, " Experimental Eye Research, vol. 151, pp. 203-211, 2016.
122. R. Pazdro and J. R. Burgess, "Therole of Vitamin E and oxidative stress in diabetes complications, " Mechanisms of Ageing and Development, vol. 131, no. 4, pp. 276-286, 2010.
123. A. Jariyapongskul, T. Rungjaroen, N. Kasetsuwan, S. Patumraj, J. Seki, and H. Niimi, "Long-term effects of oral Vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats, " Microvascular Research, vol. 74, no. 1, pp. 32-38, 2007.
124. M. Kunisaki, S.-E. Bursell, A. C. Clermont et al., "Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway, " American Journal of Physiology-Endocrinology and Metabolism, vol. 269, no. 2, pp. E239-E246, 1995.
125. N. Alcubierre, J. Valls, E. Rubinat et al., "VitaminDdeficiency is associated with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus, " Journal of Diabetes Research, vol. 2015, Article ID 374178, 7 pages, 2015.
126. Z. Ren, W. Li, Q. Zhao, L. Ma, and J. Zhu, "The impact of 1, 25-dihydroxy Vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-1 in the retinas of rats with diabetes, " Diabetes Research and Clinical Practice, vol. 98, no. 3, pp. 474-480, 2012.
127. W. Wang, Y. Yang, W. Zhang, andW. Wu, "Association of tea consumption and the risk of oral cancer: A meta-analysis, " Oral Oncology, vol. 50, no. 4, pp. 276-281, 2014.
128. B. Kumar, S. K. Gupta, T. C. Nag, S. Srivastava, and R. Saxena, "Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats, " Ophthalmic Research, vol. 47, no. 2, pp. 103-108, 2012.
129. M. B. Gomes and C. A. Negrato, "Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases, " Diabetology & Metabolic Syndrome, vol. 6, no. 1, article 80, 2014.
130. S. Golbidi, M. Badran, and I. Laher, "Diabetes and alpha lipoic acid, " Frontiers in Pharmacology, vol. 2, article 69, 2011.
131. J. Lin, A. Bierhaus, P. Bugert et al., "Effect of R-(+)-lipoic acid on experimental diabetic retinopathy, " Diabetologia, vol. 49, no. 5, pp. 1089-1096, 2006.
132. H.-P. Hammes, X. Du, D. Edelstein et al., "Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy, " Nature Medicine, vol. 9, no. 3, pp. 294-299, 2003.
133. E. Beltramo, K. Nizheradze, E. Berrone, S. Tarallo, andM. Porta, "Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes, " Diabetes/Metabolism Research and Reviews, vol. 25, no. 7, pp. 647-656, 2009.
134. X. Zhang, G. Barile, S. Chang et al., "Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression, " Current Eye Research, vol. 30, no. 5, pp. 395-403, 2005.
135. B. Xu, J. Chiu, B. Feng, S. Chen, and S. Chakrabarti, "PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes, " Diabetes/Metabolism Research and Reviews, vol. 24, no. 5, pp. 404-412, 2008.
136. L. Zheng, C. Szabó, and T. S. Kern, "Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-B, " Diabetes, vol. 53, no. 11, pp. 2960-2967, 2004.
137. H. Goto, T. Nishikawa, K. Sonoda et al., "Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice, " Biochemical and Biophysical Research Communications, vol. 366, no. 3, pp. 814-820, 2008.
138. R. A. Kowluru, V. Kowluru, Y. Xiong, and Y.-S. Ho, "Overexpression of mitochondrial superoxide dismutase in mice protects the retina fromdiabetes-induced oxidative stress, " Free Radical Biology andMedicine, vol. 41, no. 8, pp. 1191-1196, 2006.
139. M. A. B. Rosales, K. C. Silva, J. B. Lopes de Faria, and J. M. Lopes de Faria, "Exogenous sod mimetic tempol ameliorates the earlyretinal changes reestablishing the redox status in diabetic hypertensive rats, " Investigative Ophthalmology & Visual Science, vol. 51, no. 8, pp. 4327-4336, 2010.
140. S. A. Moustafa, "Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats, " Toxicology and Applied Pharmacology, vol. 201, no. 2, pp. 149-155, 2004.
141. J. Kim, "Pericytes and the prevention of diabetic retinopathy, " Diabetes Research and Clinical Practice, vol. 66, pp. S49-S51, 2004.
142. H. P. Hammes, A. Bartmann, L. Engel, and P. Wülfroth, "Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine, " Diabetologia, vol. 40, no. 6, pp. 629-634, 1997.
143. M.-K. Bae, S.-H. Kim, J.-W. Jeong et al., "Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1, " Oncology Reports, vol. 15, no. 6, pp. 1557-1562, 2006.
144. T. Mrudula, P. Suryanarayana, P. N. B. S. Srinivas, and G. B. Reddy, "Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina, " Biochemical and Biophysical Research Communications, vol. 361, no. 2, pp. 528-532, 2007.
145. A.-S. Kiang, M. M. Humphries, M. Campbell, and P. Humphries, "Antioxidant therapy for retinal disease, " Advances in Experimental Medicine and Biology, vol. 801, pp. 783-789, 2014.
146. M. Tanito, H. Masutani, Y.-C. Kim, M. Nishikawa, A. Ohira, and J. Yodoi, "Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice, " Investigative Ophthalmology&Visual Science, vol. 46, no. 3, pp. 979-987, 2005.
147. J. Fan, G. Xu, T. Jiang, and Y. Qin, "Pharmacologic induction of heme oxygenase-1 plays a protective role indiabetic retinopathy in rats, " Investigative Ophthalmology and Visual Science, vol. 53, no. 10, pp. 6541-6556, 2012.
148. A. S. Arellano-Buenda, M. Tostado-González, F. E. Garca-Arroyo et al., "Anti-inflammatory therapy modulates Nrf2-Keap1 in kidney from rats with diabetes, " Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4693801, 11 pages, 2016.
149. K. P. Maremanda, S. Khan, and G. B. Jena, "Role of zinc supplementation in testicular and epididymal damages in diabetic rat: involvement of Nrf2, SOD1, and GPX5, " Biological Trace Element Research, vol. 173, no. 2, pp. 452-464, 2016.
150. Z. Yu, W. Shao, Y. Chiang et al., "Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a highfat diet in C57BL/6J mice, " Diabetologia, vol. 54, no. 4, pp. 922-934, 2011.
151. S. Zhou, J. Jin, T. Bai, L. R. Sachleben, L. Cai, and Y. Zheng, "Potential drugs which activate nuclear factor E2-related factor 2 signaling to prevent diabetic cardiovascular complications: A focus on fumaric acid esters, " Life Sciences, vol. 134, no. 1, pp. 56-62, 2015.
152. K.-C. Choi, G. J. Myung, Y.-H. Lee et al., "Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBVinduced B lymphocyte transformation via suppression of RelA acetylation, " Cancer Research, vol. 69, no. 2, pp. 583-592, 2009.
153. S. Majid, A. A. Dar, A. E. Ahmadet al., "BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer, " Carcinogenesis, vol. 30, no. 4, pp. 662-670, 2009.
154. E. Tili, J.-J. Michaille, B. Adair et al., "Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD, " Carcinogenesis, vol. 31, no. 9, pp. 1561-1566, 2010.
155. Z. Zheng, H. Chen, J. Li et al., "Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects ofmetformin, " Diabetes, vol. 61, no. 1, pp. 217-228, 2012.
156. D. A. Duarte, M. A. B. Rosales, A. Papadimitriou et al., "Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway, " The Journal of Nutritional Biochemistry, vol. 26, no. 1, pp. 64-74, 2015.
157. S. Zhao, J. Li, N. Wang et al., "Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway, " Molecular Medicine Reports, vol. 12, no. 4, pp. 6112-6118, 2015.